ECSP077303A - 17-desmetilrapamicina y analogos de la misma, metodos para su produccion - Google Patents
17-desmetilrapamicina y analogos de la misma, metodos para su produccionInfo
- Publication number
- ECSP077303A ECSP077303A EC2007007303A ECSP077303A ECSP077303A EC SP077303 A ECSP077303 A EC SP077303A EC 2007007303 A EC2007007303 A EC 2007007303A EC SP077303 A ECSP077303 A EC SP077303A EC SP077303 A ECSP077303 A EC SP077303A
- Authority
- EC
- Ecuador
- Prior art keywords
- analogs
- production
- present
- compounds
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a la producción de policétidos y otros productos naturales y a genotecas de compuestos y compuestos novedosos individuales; por lo tanto en una aspecto la presente invención provee 17-desmetilrapamicina y análogos de la misma, métodos para su producción, incluyendo cepas recombinantes, y aislamiento y usos de los compuestos de la invención; en una aspecto adicional la presente invención provee el uso de 17-desmetilrapamicina y análogos de la misma en la inducción o el mantenimiento de la inmunosupresión, la estimulación de la regeneración neuronal o el tratamiento de cáncer, malignidades de células B, infecciones fúngicas, rechazo de transplante, enfermedad de injerto contra hospedero, trastornos autoinmunes, enfermedades de inflamación, enfermedad vascular y enfermedades fibróticas, y en la regulación de la cicatrización de heridas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0417852.1A GB0417852D0 (en) | 2004-08-11 | 2004-08-11 | Production of polyketides and other natural products |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP077303A true ECSP077303A (es) | 2007-04-26 |
Family
ID=33017292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2007007303A ECSP077303A (es) | 2004-08-11 | 2007-03-07 | 17-desmetilrapamicina y analogos de la misma, metodos para su produccion |
Country Status (19)
Country | Link |
---|---|
US (1) | US7803808B2 (es) |
EP (2) | EP2471797B1 (es) |
JP (1) | JP2008509895A (es) |
KR (1) | KR20070052784A (es) |
CN (2) | CN101056880A (es) |
AU (1) | AU2005270989B2 (es) |
BR (1) | BRPI0514236A (es) |
CA (1) | CA2575582A1 (es) |
CR (1) | CR8990A (es) |
EC (1) | ECSP077303A (es) |
GB (1) | GB0417852D0 (es) |
IL (1) | IL181171A0 (es) |
MX (1) | MX2007001809A (es) |
NO (1) | NO20070686L (es) |
NZ (1) | NZ553074A (es) |
RU (2) | RU2430922C2 (es) |
UA (1) | UA95895C2 (es) |
WO (1) | WO2006016167A2 (es) |
ZA (1) | ZA200701622B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006221774A1 (en) * | 2005-03-11 | 2006-09-14 | Biotica Technology Limited | Medical uses of 39-desmethoxyrapamycin and analogues thereof |
JP2008534442A (ja) * | 2005-03-11 | 2008-08-28 | バイオティカ テクノロジー リミテッド | 化合物の用途 |
GB0504994D0 (en) | 2005-03-11 | 2005-04-20 | Biotica Tech Ltd | Novel compounds |
GB0609963D0 (en) * | 2006-05-19 | 2006-06-28 | Biotica Tech Ltd | Novel compounds |
WO2007144876A1 (en) * | 2006-06-12 | 2007-12-21 | Ramot At Tel-Aviv University Ltd. | Methods for treating cancer |
US8063075B2 (en) | 2008-06-10 | 2011-11-22 | Hoffmann-La Roche Inc. | Pyrrolidine ether derivatives as NK3 receptor antagonists |
CA2819501C (en) | 2010-11-30 | 2020-03-31 | The Johns Hopkins University | Hybrid cyclic libraries and screens thereof |
GB201122305D0 (en) * | 2011-12-23 | 2012-02-01 | Biotica Tech Ltd | Novel compound |
WO2014100742A2 (en) | 2012-12-21 | 2014-06-26 | The Regents Of The University Of California | Modulation of expression of acyltransferases to modify hydroxycinnamic acid content |
GB201312318D0 (en) | 2013-07-09 | 2013-08-21 | Isomerase Therapeutics Ltd | Novel methods and compounds |
AU2017214550B2 (en) | 2016-02-04 | 2024-03-07 | The Johns Hopkins University | Synthesis and composition of Rapafucin libraries |
US11066416B2 (en) | 2016-02-04 | 2021-07-20 | The Johns Hopkins University | Rapafucin derivative compounds and methods of use thereof |
MX2018009408A (es) | 2016-02-04 | 2018-11-09 | Univ Johns Hopkins | Rapaglutinas, nuevos inhibidores de transportadores de glucosa (glut) y uso de los mismos. |
WO2017136717A1 (en) | 2016-02-04 | 2017-08-10 | The Johns Hopkins University | Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof |
AU2018219317A1 (en) | 2017-02-10 | 2019-09-26 | Mount Tam Therapeutics, Inc. | Rapamycin analog |
CN108456213B (zh) * | 2017-02-22 | 2021-01-15 | 浙江九洲药业股份有限公司 | 一种3-氟-4-羟基环己烷羧酸酯的制备方法 |
CN107629994B (zh) * | 2017-10-25 | 2021-11-02 | 中国科学院上海有机化学研究所 | 一种构建fk520高产工程菌株的方法和吸水链霉菌高产菌株 |
WO2020076738A2 (en) * | 2018-10-12 | 2020-04-16 | Bellicum Pharmaceuticals, Inc | Protein-binding compounds |
CN109467579B (zh) * | 2018-11-01 | 2021-10-15 | 海南大学 | 一种具有免疫抑制活性的pks i型聚酮类化合物及其制备方法和应用 |
CN110627702B (zh) * | 2019-10-18 | 2022-11-15 | 福建师范大学 | 聚酮化合物及其制备方法和用途 |
EP3854350A1 (en) | 2020-01-23 | 2021-07-28 | Kardiozis SAS | Endoprosthesis and method of manufacturing an endoprosthesis |
EP3854349A1 (en) | 2020-01-23 | 2021-07-28 | Kardiozis SAS | Endoprosthesis and method of manufacturing an endoprosthesis |
EP3854348A1 (en) | 2020-01-23 | 2021-07-28 | Kardiozis SAS | Endoprosthesis and method of attaching a fiber to a surface |
CN115125179B (zh) * | 2021-03-26 | 2023-10-27 | 上海医药工业研究院 | 产雷帕霉素的基因工程菌及其应用 |
WO2022272129A1 (en) * | 2021-06-25 | 2022-12-29 | Edmund Graziani | Small molecule compounds |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA737247B (en) | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
US3993479A (en) | 1975-08-04 | 1976-11-23 | Olin Corporation | Copper base alloy |
US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
US4447223A (en) | 1982-04-16 | 1984-05-08 | Cct Associates | Medicament implant applicator |
US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
US5109112A (en) | 1989-01-19 | 1992-04-28 | Merck & Co., Inc. | FK-506 cytosolic binding protein |
US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
US5023262A (en) | 1990-08-14 | 1991-06-11 | American Home Products Corporation | Hydrogenated rapamycin derivatives |
US5221670A (en) | 1990-09-19 | 1993-06-22 | American Home Products Corporation | Rapamycin esters |
US5138051A (en) | 1991-08-07 | 1992-08-11 | American Home Products Corporation | Rapamycin analogs as immunosuppressants and antifungals |
CA2102116A1 (en) | 1991-05-31 | 1992-12-01 | Gary R. Schulte | Use of rapamycin prodrugs as immunosuppressant agents |
US5763590A (en) | 1991-10-11 | 1998-06-09 | Vertex Pharmaceuticals, Inc. | Isolation of an Mr 52,000 FK506 binding protein and molecular cloning of a corresponding human cDNA |
US5498597A (en) | 1992-01-17 | 1996-03-12 | Dana-Farber Cancer Institute, Inc. | FKBP-13, an FK506-binding immunophilin |
ZA935112B (en) | 1992-07-17 | 1994-02-08 | Smithkline Beecham Corp | Rapamycin derivatives |
US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
CA2106034A1 (en) * | 1992-09-24 | 1994-03-25 | Ralph J. Russo | 21-norrapamycin |
GB9221220D0 (en) | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
US5354845A (en) | 1993-04-21 | 1994-10-11 | Children's Research Institute | FK-506 and rapamycin specific binding immunophilin |
US5391730A (en) | 1993-10-08 | 1995-02-21 | American Home Products Corporation | Phosphorylcarbamates of rapamycin and oxime derivatives thereof |
US5378836A (en) | 1993-10-08 | 1995-01-03 | American Home Products Corporation | Rapamycin oximes and hydrazones |
US5373014A (en) | 1993-10-08 | 1994-12-13 | American Home Products Corporation | Rapamycin oximes |
ATE191218T1 (de) | 1993-12-17 | 2000-04-15 | Novartis Ag | Rapamycin-derivate als immunosuppressoren |
US5457182A (en) | 1994-02-15 | 1995-10-10 | Merck & Co., Inc. | FK-506 cytosolic binding protein, FKBP12.6 |
US5362718A (en) | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
US5563145A (en) | 1994-12-07 | 1996-10-08 | American Home Products Corporation | Rapamycin 42-oximes and hydroxylamines |
ATE228135T1 (de) | 1995-06-09 | 2002-12-15 | Novartis Erfind Verwalt Gmbh | Rapamycinderivate |
US5780462A (en) | 1995-12-27 | 1998-07-14 | American Home Products Corporation | Water soluble rapamycin esters |
GB9710962D0 (en) * | 1997-05-28 | 1997-07-23 | Univ Cambridge Tech | Polyketides and their synthesis |
EP0910633B1 (en) | 1996-07-05 | 2009-12-09 | Biotica Technology Limited | Hybrid polyketide synthase I gene |
DK0956034T3 (da) | 1996-07-30 | 2002-12-16 | Novartis Ag | Farmaceutiske præparater til behandling af transplantatafstødning, autoimmune eller inflammatoriske tilstande omfattende cyclosporin A og 40-O-(2-hydroxyethyl)-rapamycin |
US6015815A (en) | 1997-09-26 | 2000-01-18 | Abbott Laboratories | Tetrazole-containing rapamycin analogs with shortened half-lives |
GB9814006D0 (en) | 1998-06-29 | 1998-08-26 | Biotica Tech Ltd | Polyketides and their synthesis |
GB9814622D0 (en) | 1998-07-06 | 1998-09-02 | Biotica Tech Ltd | Polyketides,their preparation,and materials for use therein |
JP2003504330A (ja) | 1999-07-09 | 2003-02-04 | オレゴン ヘルス アンド サイエンス ユニバーシティー | 神経再生を促進するための組成物および方法 |
IL147803A0 (en) * | 1999-08-24 | 2002-08-14 | Ariad Gene Therapeutics Inc | 28-epirapalogs |
ATE356880T1 (de) | 1999-10-29 | 2007-04-15 | Kosan Biosciences Inc | Rapamycin analoge |
DE60140936D1 (de) | 2000-04-13 | 2010-02-11 | Biotica Tech Ltd | Glycosylierte hybrid-verbindungen, deren herstellung und verwendung |
US6776796B2 (en) | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
GB0019986D0 (en) | 2000-08-14 | 2000-10-04 | Biotica Tech Ltd | Polyketides and their synthesis |
GB0125043D0 (en) | 2001-10-17 | 2001-12-12 | Biotica Tech Ltd | Production, detection and use of transformant cells |
GB0128680D0 (en) | 2001-11-29 | 2002-01-23 | Biotica Tech Ltd | Hybrid glycosylated products and their production and use |
US20030225006A1 (en) | 2002-02-19 | 2003-12-04 | Burns Lesley S | Novel spinosyn-producing polyketide synthases |
EP1521828B1 (en) | 2002-07-16 | 2015-07-01 | Buck Institute for Research on Aging | Production of polyketides |
-
2004
- 2004-08-11 GB GBGB0417852.1A patent/GB0417852D0/en not_active Ceased
-
2005
- 2005-08-11 EP EP12153347.5A patent/EP2471797B1/en not_active Not-in-force
- 2005-08-11 BR BRPI0514236-9A patent/BRPI0514236A/pt not_active IP Right Cessation
- 2005-08-11 CA CA002575582A patent/CA2575582A1/en not_active Abandoned
- 2005-08-11 MX MX2007001809A patent/MX2007001809A/es not_active Application Discontinuation
- 2005-08-11 KR KR1020077005523A patent/KR20070052784A/ko not_active Application Discontinuation
- 2005-08-11 WO PCT/GB2005/003158 patent/WO2006016167A2/en active Application Filing
- 2005-08-11 CN CNA2005800346333A patent/CN101056880A/zh active Pending
- 2005-08-11 ZA ZA200701622A patent/ZA200701622B/xx unknown
- 2005-08-11 CN CN200910168702A patent/CN101805748A/zh active Pending
- 2005-08-11 UA UAA200702428A patent/UA95895C2/ru unknown
- 2005-08-11 AU AU2005270989A patent/AU2005270989B2/en not_active Ceased
- 2005-08-11 NZ NZ553074A patent/NZ553074A/en not_active IP Right Cessation
- 2005-08-11 EP EP05775779A patent/EP2029611A2/en not_active Withdrawn
- 2005-08-11 US US11/659,936 patent/US7803808B2/en not_active Expired - Fee Related
- 2005-08-11 JP JP2007525355A patent/JP2008509895A/ja active Pending
- 2005-08-11 RU RU2007108772/10A patent/RU2430922C2/ru not_active IP Right Cessation
-
2007
- 2007-02-05 IL IL181171A patent/IL181171A0/en unknown
- 2007-02-06 NO NO20070686A patent/NO20070686L/no not_active Application Discontinuation
- 2007-03-07 EC EC2007007303A patent/ECSP077303A/es unknown
- 2007-03-12 CR CR8990A patent/CR8990A/es not_active Application Discontinuation
-
2009
- 2009-10-30 RU RU2009140290/04A patent/RU2009140290A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0514236A (pt) | 2008-06-03 |
US20090253732A1 (en) | 2009-10-08 |
CN101805748A (zh) | 2010-08-18 |
RU2430922C2 (ru) | 2011-10-10 |
RU2007108772A (ru) | 2008-09-20 |
ZA200701622B (en) | 2008-06-25 |
CA2575582A1 (en) | 2006-02-16 |
AU2005270989A1 (en) | 2006-02-16 |
EP2471797B1 (en) | 2016-02-03 |
MX2007001809A (es) | 2007-10-08 |
AU2005270989B2 (en) | 2012-04-05 |
WO2006016167A3 (en) | 2006-04-13 |
CN101056880A (zh) | 2007-10-17 |
CR8990A (es) | 2009-01-14 |
WO2006016167A2 (en) | 2006-02-16 |
RU2009140290A (ru) | 2011-05-10 |
EP2471797A2 (en) | 2012-07-04 |
IL181171A0 (en) | 2007-07-04 |
US7803808B2 (en) | 2010-09-28 |
EP2471797A3 (en) | 2012-10-17 |
UA95895C2 (ru) | 2011-09-26 |
EP2029611A2 (en) | 2009-03-04 |
GB0417852D0 (en) | 2004-09-15 |
NO20070686L (no) | 2007-04-25 |
KR20070052784A (ko) | 2007-05-22 |
NZ553074A (en) | 2011-01-28 |
JP2008509895A (ja) | 2008-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP077303A (es) | 17-desmetilrapamicina y analogos de la misma, metodos para su produccion | |
NI200700230A (es) | Derivados 39-desmetoxi de rapamicina | |
CA2925624C (en) | Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease | |
CL2011003346A1 (es) | Compuestos derivados de 2,3-dihidro-5h-[1,3]tiazolo[3,2-a]pirimidin-5-ona, moduladores de pi3k; composicion farmaceutica; y uso para tratar una enfermedad de base inmunologica, cancer o enfermedad pulmonar en un paciente. | |
EA200901211A1 (ru) | Антигены белка с5 и их применение | |
PH12020551043A1 (en) | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues | |
ECSP11011067A (es) | Compuestos para el tratamiento de enfermedades y desórdenes oftalmológicos | |
CR20110608A (es) | Derivados de 1h-imidazo-[4,5-c]-quinolinona | |
AR072442A1 (es) | Metodo para la terapia del cancer, uso, kit | |
MX2022011676A (es) | Proteinas de fusion de il12 con enmascaramiento y metodos para su uso. | |
CR7673A (es) | Antranilamidopirimidinas que inhiben vegfr-2 y vegfr-3 | |
UY29899A1 (es) | Uso de flibanserina para el tratamiento de trastornos del deseo sexual premenopausicos | |
GT200600297A (es) | Nuevos anticuerpos anti-madcam | |
EA201490546A1 (ru) | Замещенные аннелированные пиримидины и их применение | |
CR9994A (es) | Vacuna terapéutica | |
UY28860A1 (es) | Procedimiento para el tratamiento de trastornos premenstruales y otros trastornos sexuales femeninos | |
UY32882A (es) | (heteroarilmetil) tiohidantoínas sustituidas | |
WO2006023452A3 (en) | Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases | |
AR093182A1 (es) | Metodo para tratar el sobrepeso o la obesidad | |
RU2010103781A (ru) | Противоопухолевые комбинации, содержащие ингибитор vegf и иринотекан | |
UY28313A1 (es) | Nonadepsipeptidos acilados | |
CY1111353T1 (el) | Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης | |
AR053775A1 (es) | Nonadepsipeptidos acilados ii | |
EA201992389A1 (ru) | Замещенные n-арилэтил-2-аминохинолин-4-карбоксамиды и их применение | |
ECSP077843A (es) | Tratamiento o prevención del prurito |